ema prac naion semaglutide The use of medicines and risk of non-arteritic anterior ischemic optic neuropathy (NAION) GLP-1 Drug Can Cause Rare,

Dr Winnett says that whilst the medications have changed lives for many of his patients, they are not a magic carpet ride

A study, by Michael Nauck and colleagues from Bad Lauterberg im Harz, Germany, suggests that taspoglutide (R1583), a long-acting (once-weekly) human glucagon-like peptide-1 (GLP-1) analogue, currently under investigation by Roche for the treatment of type 2 diabetes mellitus, may likewise promote modest weight loss (Diabetes Care)

Anti-CD40L immune complexes potently activate platelets in vitro and cause thrombosis in FCGR2A transgenic mice

Changes in the Balance of Th17/Treg Cells and Oxidative Stress Markers in Patients with HIV-associated Pulmonary Tuberculosis Who Develop IRIS